Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check5 days agoChange DetectedNew revision tag v3.4.3 was added to the page history and the previous tag v3.4.2 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry (v3.4.2) was added to the study history. The deletions include a site-wide funding notice and the previous revision (v3.4.1).SummaryDifference0.8%

- Check41 days agoChange DetectedA government funding notice banner and a revision label to v3.4.1 were added, and the prior revision label v3.4.0 was removed.SummaryDifference0.8%

- Check48 days agoChange DetectedUI updates add a glossary toggle, color-coded additions in green and deletions in red to the record history, and update the revision label from v3.3.4 to v3.4.0.SummaryDifference1.0%

- Check62 days agoChange DetectedThe record history now includes a new revision entry (v3.3.4) and removes the previous entry (v3.3.3), reflecting administrative version tracking. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry (v3.3.3) was added to the record history, and an older revision (v3.3.2) along with the HHS Vulnerability Disclosure footer link were removed; these are metadata updates to the record history and do not affect the study's data or outcomes.SummaryDifference0.2%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.